New York State Common Retirement Fund Caribou Biosciences, Inc. Transaction History

New York State Common Retirement Fund

$74.9 Billion
Q3 2025

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2025	BUY	$1.56 - $2.73 $53,520 - $93,660	34,308 New	34,308 $66,000
Q2 2024 Oct 08, 2025	BUY	$1.62 - $5.05 $55,578 - $173,255	34,308 New	34,308 $56,000
Q2 2024 Jul 31, 2024	BUY	$1.62 - $5.05 $123 - $383	76 Added 0.22%	34,308 $56,000
Q1 2024 Oct 08, 2025	BUY	$4.82 - $8.26 $164,998 - $282,756	34,232 New	34,232 $175,000
Q1 2024 May 07, 2024	SELL	$4.82 - $8.26 $81 - $140	-17 Reduced 0.05%	34,232 $176,000

Q4 2023 Oct 08, 2025	BUY	$3.58 - $6.25 $122,611 - $214,056	34,249 New	34,249 $196,000
Q4 2023 Feb 01, 2024	BUY	$3.58 - $6.25 $67,529 - $117,893	18,863 Added 122.6%	34,249 $196,000
Q3 2023 Oct 08, 2025	BUY	$4.08 - $8.14 $62,774 - $125,242	15,386 New	15,386 $73,000
Q3 2023 Nov 07, 2023	BUY	$4.08 - $8.14 $1,558 - $3,109	382 Added 2.55%	15,386 $74,000
Q2 2023 Oct 08, 2025	BUY	$4.04 - $5.47 $60,616 - $82,071	15,004 New	15,004 $63,000
Q2 2023 Aug 07, 2023	SELL	$4.04 - $5.47 $270 - $366	-67 Reduced 0.44%	15,004 $64,000
Q1 2023 Oct 08, 2025	SELL	$4.3 - $7.78 $200,908 - $363,504	-46,723 Reduced 75.61%	15,071 $80,000
Q1 2023 May 02, 2023	SELL	$4.3 - $7.78 $200,908 - $363,504	-46,723 Reduced 75.61%	15,071 $80,000
Q4 2022 Oct 08, 2025	BUY	$5.57 - $11.01 $344,192 - $680,351	61,794 New	61,794 $388,000
Q4 2022 Jan 30, 2023	SELL	$5.57 - $11.01 $22 - $44	-4 Reduced 0.01%	61,794 $388,000
Q3 2022 Nov 08, 2022	BUY	$5.34 - $12.79 $94,699 - $226,817	17,734 Added 40.25%	61,798 $652,000
Q2 2022 Aug 04, 2022	SELL	$5.1 - $9.74 $102,372 - $195,511	-20,073 Reduced 31.3%	44,064 $239,000
Q1 2022 May 05, 2022	BUY	$8.42 - $15.32 $359,449 - $654,010	42,690 Added 199.05%	64,137 $589,000
Q4 2021 Feb 02, 2022	BUY	$14.59 - $23.26 $59,614 - $95,040	4,086 Added 23.54%	21,447 $324,000
Q3 2021 Nov 02, 2021	BUY	$15.75 - $30.29 $273,435 - $525,864	17,361 New	17,361 $414,000

Others Institutions Holding CRBU

# of Institutions

123

Shares Held

39.9M

Call Options Held

42.2K

Put Options Held

93.2K

Black Rock Inc. New York, NY

6.95M
Shares

$14.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.23M
Shares

$8.58 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.22M
Shares

$6.53 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

3.07M
Shares

$6.23 Million
0.6% of portfolio
Pictet Asset Management Sa Geneva 73, V8

1.81M
Shares

$3.67 Million
0.01% of portfolio

View Full List

About Caribou Biosciences, Inc.

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $124M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

More about CRBU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account